The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital in Martinique

ConditionsCardiogenic Shock Malignant Arrhythmias Ischemic or Valvular Heart Failure Drepanocytosis and Thoracic Syndrome Pulmonary Thromboembolisms Sepsis ARDS (Acute Respiratory Distress Syndrome)Intoxication Cardiac Arrest (CA)Postcardiotomy Heart Failure Acute Respiratory Failure

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeUp to 90

SponsorUniversity of Genova

About this trial

The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing VV, VA or VAV ECMO implantation in the French West Indies and Guiana. All patients undergoing ECMO implantation will be prospectively registered.

Eligibility criteria

Qualifiers

All consecutive patients implanted with a veno-venous extracorporeal membrane oxygenation device or extracorporeal membrane oxygenation device by the HeartTeam from the University Hospital of Martinique (UHM) from January 2010

Disqualifiers

Patients with incomplete data (primary endpoint and less than 80% secondary study outcomes)

Trial design

Treatments tested in this trial

Not listed

Trial groups

1,200 Participants

are grouped into 3 trial groups

Locations

This trial has no locations

Sponsors and collaborators

University of Genova

Lead sponsor

Source ClinicalTrials.gov